Shouyao Holdings (Beijing) Co. Ltd. A (688197) fair value: what the stock is really worth
As of Nov 17, 2026: fair value (intrinsic value) of Shouyao Holdings (Beijing) Co. Ltd. A stock ¥18.47, price ¥31.36, that is 41.1% below the price, quality 48 out of 100. Rating: strongly overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Shouyao Holdings (Beijing) Co. Ltd. A
688197 · SHGFar too expensive (fair value 41% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
56‑month range ¥17.97 – ¥66.15 · fair‑value band ¥13.85 – ¥23.09 · the ¥31.36 price screens above the ¥18.47 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Shouyao Holdings (Beijing) Co. Ltd. A is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China.
Show moreShow less
The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China.
Stock analysis
Shouyao Holdings (Beijing) Co. Ltd. A (688197) currently trades at ¥31.36, while our estimate is ¥18.47, 41% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: ¥13.85 (bear) to ¥23.09 (bull), the price of ¥31.36 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Shouyao Holdings (Beijing) Co. Ltd. A reported revenue of 8.7M CNY in FY2025 versus 13.0M CNY in FY2021, a compound −9.7%/yr. Reported net income was −129M CNY in FY2025.
Key figures
Market cap 4.7B CNY (≈ $701M) Small · EPS (TTM) ¥−0.1300 · Return on equity −12.9% · Return on assets (EBIT) −65.9% (5-year average) · Operating margin −464% · Revenue growth (YoY) +13.0% · Free cash flow −161M CNY.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 23 out of 100 (medium confidence).
What moves the price
The share trades about 28% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −41%, 688197 screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Shouyao Holdings (Beijing) Co. Ltd. A with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 850 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- EV/EBITDA by industry
- Dividend yield by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Chinese Stocks
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $952.40 | $1,275 | +34% | vs 688197 |
| Vertex Pharmaceuticals Incorporated VRTX | $537.79 | $592.46 | +10% | vs 688197 |
| Samsung Biologics Co 207940 | 1,414,000 KRW | 1,552,100 KRW | +10% | vs 688197 |
| argenx SE ARGX | $950.95 | $908.40 | −4% | vs 688197 |
| CSL Limited CSL | A$199.55 | A$186.49 | −7% | vs 688197 |
| Moderna, Inc MRNA | $215.27 | $135.64 | −37% | vs 688197 |
| BeOne Medicines AG 6160 | HK$247.40 | HK$152.92 | −38% | vs 688197 |
| Revolution Medicines, Inc RVMD | $166.87 | $88.78 | −47% | vs 688197 |
| Celltrion, Inc 068270 | 213,000 KRW | 74,945 KRW | −65% | vs 688197 |
| Royalty Pharma plc RPRX | $68.53 | $19.01 | −72% | vs 688197 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Shouyao Holdings (Beijing) Co. Ltd. A (688197) overvalued or undervalued?
What is the fair value of 688197?
What is the quality score of 688197?
What is the price target for Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
What is the Shouyao Holdings (Beijing) Co. Ltd. A stock forecast for 2026?
What is the intrinsic value of Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
Is Shouyao Holdings (Beijing) Co. Ltd. A stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 688197?
How much is Shouyao Holdings (Beijing) Co. Ltd. A worth?
What do the bullish and bearish scenarios say about 688197?
How solid is the balance sheet of Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
How far is 688197 from its 52-week high?
Which stocks are comparable to Shouyao Holdings (Beijing) Co. Ltd. A?
Is Shouyao Holdings (Beijing) Co. Ltd. A stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
What should I pay attention to with Shouyao Holdings (Beijing) Co. Ltd. A right now?
Key figures of Shouyao Holdings (Beijing) Co. Ltd. A
How large is the market capitalisation of Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
What are the earnings per share of Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
What is the return on equity of Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
What is the EBIT return on assets of Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
What is the operating margin of Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
How fast is revenue growing at Shouyao Holdings (Beijing) Co. Ltd. A (688197)?
How much free cash flow does Shouyao Holdings (Beijing) Co. Ltd. A (688197) generate?
Watch Shouyao Holdings (Beijing) Co. Ltd. A in the live analysis
One click puts Shouyao Holdings (Beijing) Co. Ltd. A on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.